Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

334 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 334 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Post-approval studies (Phase 4)Looking for participantsNCT05629494
What this trial is testing

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Who this might be right for
Prostate CancerProstate InflammationPSA
Albany Medical College 198
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Large-scale testing (Phase 3)Ended earlyNCT03535675
What this trial is testing

Muscadine Plus (MPX) In Men With Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Testing effectiveness (Phase 2)Study completedNCT02047253
What this trial is testing

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Alabama at Birmingham 28
Early research (Phase 1)Looking for participantsNCT07621692
What this trial is testing

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
National Taiwan University Hospital 12
Early research (Phase 1)Looking for participantsNCT07082920
What this trial is testing

JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Study completedNCT06849544
What this trial is testing

Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection

Who this might be right for
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler 22
Not applicableUnknownNCT04026763
What this trial is testing

MR/TRUS Fusion Guided Prostate Biopsy

Who this might be right for
Prostate DiseaseElevated Prostate Specific AntigenFamily History of Prostate Cancer+1 more
Icahn School of Medicine at Mount Sinai 520
Post-approval studies (Phase 4)Study completedNCT01296672
What this trial is testing

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 383
Early research (Phase 1)Study completedNCT02552394
What this trial is testing

J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 10
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Testing effectiveness (Phase 2)Ended earlyNCT03463889
What this trial is testing

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Who this might be right for
Thyroid Gland Carcinoma
University of California, San Francisco 12
Not applicableLooking for participantsNCT06862856
What this trial is testing

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen
Massachusetts General Hospital 50
Next Page